• Skip to primary navigation
  • Skip to main content

New York Society of Addiction MedicineNew York Society of Addiction Medicine Logo

  • NYSAM on Twitter
  • NYSAM on Facebook
  • NYSAM on LinkedIn
  • Join Mailing List
  • Past Conferences
  • 2023 Annual Conference
  • About Addiction Medicine
  • Key Issues
    • Advocacy
    • Opioids
    • Marijuana
    • Access to Care
    • More Issues
  • About
    • About NYSAM
    • Leadership
    • Contact NYSAM
    • News
    • Annual Conference
  • Resources
    • For Patients
    • For Physicians
    • Webinars
    • Articles
    • Employment
  • Membership
    • NYSAM Committees
    • Become a NYSAM Member
    • Renew Membership
    • Our Members
  • Annual Conference
  • Past Conferences
  • Donate
  • Sign Up for Our Newsletter

Articles

May 20, 2023 by NYSAMGeneral

Methadone Treatment in Primary Care: Experience from Ontario, Canada 1980-2021

Webinar – Wednesday, May 31st @ 7pm ET Lori Regenstreif, MD Andrew McLeod Meldon Kahan, MD As the United States…

May 1, 2023 by NYSAMGeneral

New OASAS Medical Advisory Panel (MAP) Xylazine Guidance

OASAS has posted the new OASAS Medical Advisory Panel (MAP) Xylazine Guidance document. Please share widely with your staff. Please…

April 26, 2023 by NYSAMGeneral

Pilot Funding Opportunity: One Year Up to $75,000 for Research

One year of pilot funding of up to $75,000 for research into chronic pain and opioid use disorder IMPOWR-ME is…

April 17, 2023 by NYSAMGeneral

Learning Session May 1st – Evidence for the Use of PrEP

Please join us for our upcoming General Membership Learning Session, scheduled for Monday, May 1st from 8-9PM. Pamela Mund, MD,…

March 30, 2023 by NYSAMMeetings

NYSPA Addictions Division In-Person Conference

Join The Division on Addictions of the New York State Psychological Association (NYSPA) and the Concentration in Mental Health and…

March 30, 2023 by NYSAMNews

FDA Approves Over-the-Counter Naloxone

On March 29th, the the U.S. Food and Drug Administration (FDA) approved the first nonprescription, “over-the-counter” (OTC) naloxone nasal spray, Narcan. This…

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 20
  • Go to Next Page »

View by Topic

  • All Topics
  • Access to Care
  • Advocacy
  • Alcohol
  • Archive
  • Benzodiazepines
  • CME
  • Employment
  • Evidence-based Research
  • General
  • Harm reduction
  • Marijuana
  • Meetings
  • News
  • Opioids
  • Stimulants
  • Webinars

Connect with Us

  • NYSAM on Twitter
  • NYSAM on Facebook
  • NYSAM on LinkedIn

Join our mailing list to stay updated on upcoming events and chapter news.

  • This field is for validation purposes and should be left unchanged.

NYSAM is a State Chapter of the American Society of Addiction Medicine (ASAM)

  • Become a Member
  • About Addiction Medicine
  • Addiction Resources
  • Physician Resources
  • Key Issues
NYSAM logo in footer

865 Merrick Avenue
Westbury, NY 11590

For inquiries, contact Philip Schuh, CPA,MS, Executive Vice President MSSNY
516-488-6100, ext.397
nysocietyofaddictionmedicine@gmail.com

© 2023 New York Society of Addiction Medicine. Website by Status Forward.

Join the Conversation

Stay Informed. Share your views.

For the latest news and evidence on substance use disorders and addiction, follow NYSAM on Twitter.

Follow Us

×